OTC · Biotechnology

Devonian Health Group Inc. (DVHGF) Stock

$7.00 +0.00% OTC: DVHGF Healthcare

Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs.

Valuation

MetricValue
Price$7.00
Market Cap$19.47M
P/E Ratio-4.51
P/B Ratio3.92
P/S Ratio10.39
EPS (TTM)$-1.76
52-Week High$10.80
52-Week Low$4.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-77.36%
ROA-69.69%
ROCE-86.46%
Gross Margin58.11%
Operating Margin-230.37%
Net Margin-227.68%
Debt/Equity0.02
Current Ratio0.91

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$2.0M$2.0M$18.0M$17.0M
Operating Profit$-2.0M$-3.0M$-4.0M$-1.0M$-1.0M
Net Profit$-3.0M$-3.0M$-5.0M$-1.0M$-4.0M
EPS$-2.26$-1.74$-2.03$-0.50$-1.76
Op Margin-156.4%-126.3%-182.6%-4.8%-6.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$15.0M$22.0M$19.0M$31.0M$11.0M
Total Liabilities$7.0M$5.0M$5.0M$16.0M$7.0M
Cash$0$3.0M$5.0M$10.0M$5.0M
Borrowings$5.0M$4.0M$4.0M$2.0M$0

Latest News

Devonian Health Group Receives Health Canada Nod For Thykamine Trial in Children MT Newswires · Jul 21, 2026 Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months to 17 Years PR Newswire · Jul 21, 2026 Devonian Health Posts Narrower Q3 Net Loss MT Newswires · Jun 30, 2026 Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026 CNW Group · Jun 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-3.0M$-4.0M$6.0M$-1.0M
Investing Cash Flow$0$-5.0M$5.0M$0$0
Financing Cash Flow$0$0$1.0M$0$0
Net Cash Flow$-1.0M$2.0M$2.0M$5.0M$-2.0M
Free Cash Flow$-2.0M$-3.0M$-4.0M$6.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.09
EV / EBITDA-2.46
FCF Yield-42.95%
Quick Ratio0.91
Interest Coverage-473.44
Return 1Y-35.19%
Return 3Y-26.95%
Return 5Y—

Ownership

Insiders Held12.04%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ECGSEco-Growth Strategies Inc. $0.04 -23.21% -2.54 $2.45M 0.00%
HMTXFHemostemix Inc $0.05 -14.81% -2.53 $9.22M 0.00%
HOOKHOOKIPA Pharma Inc. $1.15 +0.00% -0.71 $14.40M 0.00%
IMUCEOM Pharmaceuticals Holdings, Inc. $0.25 +90.77% -16.32 $31.37M 0.00%
INTIInhibitor Therapeutics, Inc. $0.09 +0.00% -4.48 $15.01M 0.00%

About Devonian Health Group Inc.

Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.

Devonian Health Group Inc. is headquartered in CA.

Devonian Health Group Inc. (DVHGF) stock trades at $7.00 with a market capitalization of $19.47M. The stock is valued at a price-to-earnings (P/E) ratio of -4.51, price-to-book of 3.92, price-to-sales of 10.39. Over the past 52 weeks the stock has ranged between $4.27 and $10.80, and currently trades 35.2% below its 52-week high.

On profitability, Devonian Health Group Inc. generates a return on equity (ROE) of -77.36%, return on capital employed of -86.46%, an operating margin of -230.37%, a net profit margin of -227.68%.

Official website: groupedevonian.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides